1)島崎 潤・横井則彦・渡辺 仁・他:日本のドライアイの定義と診断基準の改訂(2016年版).あたらしい眼科34:3-8,2017
2)Yokoi N, Georgiev GA, Kato H et al:Classification of Fluorescein Breakup Patterns:A Novel Method of Differential Diagnosis for Dry Eye. Am J Ophthalmol 180:72-85, 2017
3)Craig JP, Nichols KK, Akpek EK et al:TFOS DEWS Ⅱ Definition and Classification Report. Ocular Surf 15:276-283, 2017
4)The 2007 International Dry Eye WorkShop:The definition and classification of dry eye disease:report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop(2007). Ocular Surf 5:75-92, 2007
5)Bron AJ, de Paiva CS, Chauhan SK et al:TFOS DEWS Ⅱ pathophysiology report. Ocular Surf 15:438-510, 2017
6)Luo L, Li DQ, Doshi A et al:Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 45:4293-4301, 2004
7)Lam H, Bleiden L, de Paiva CS et al:Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 147:198-205 e191, 2009
8)Chotikavanich S, de Paiva CS, Li de Q et al:Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 50:3203-3209, 2009
9)Luo L, Li DQ, Corrales RM et al:Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 31:186-193, 2005
10)Igarashi T, Fujimoto C, Suzuki H et al:Short-time exposure of hyperosmolarity triggers interleukin-6 expression in corneal epithelial cells. Cornea 33:1342-1347, 2014
11)Stern ME, Gao J, Schwalb TA et al:Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci 43:2609-2614, 2002
12)Niederkorn JY, Stern ME, Pflugfelder SC et al:Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol 176:3950-3957, 2006
13)Schaumburg CS, Siemasko KF, De Paiva CS et al:Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol 187:3653-3662, 2011
14)De Paiva CS, Chotikavanich S, Pangelinan SB et al:IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2:243-253, 2009
15)Chauhan SK, El Annan J, Ecoiffier T et al:Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 182:1247-1252, 2009
16)Stevenson W, Chauhan SK, Dana R:Dry eye disease:an immune-mediated ocular surface disorder. Arch Ophthalmol 130:90-100, 2012
17)Sheppard JD, Torkildsen GL, Lonsdale JD et al:Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease:results of the OPUS-1 phase 3 study. Ophthalmology 121:475-483, 2014
18)Reyes JL, Vannan DT, Eksteen B et al:Innate and adaptive cell populations driving inflammation in dry eye disease. Mediators Inflamm 2018:2532314, 2018
19)Lemp MA, Bron AJ, Baudouin C et al:Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 151:792-798, e791, 2011
20)Sullivan BD, Whitmer D, Nichols KK et al:An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 51:6125-6130, 2010
21)Amparo F, Jin Y, Hamrah P et al:What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? Am J Ophthalmol 157:69-77, e62, 2014
osmometer. Graefes Arch Clin Exp Ophthalmol 250:1201-1205, 2012
23)一戸 唱・五十嵐 勉・藤本千明・他・自発的開瞼維持による涙液浸透圧の変化.あたらしい眼科31:97-99,2014
24)Hirata H, Mizerska K, Dallacasagrande V et al:Estimating the osmolarities of tears during evaporation through the“eyes”of the corneal nerves. Invest Ophthalmol Vis Sci 58:168-178, 2017
25)Peng CC, Cerretani C, Braun RJ et al:Evaporation-driven instability of the precorneal tear film. Adv Colloid Interface Scie 206:250-264, 2014
26)Liu H, Begley C, Chen M et al:A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci 50:3671-3679, 2009